CSE:SENS

Senseonics Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Senseonics (CSE:SENS) Vs. AKU, LXG, SQD, SVA, GEN, and LMD

Should you be buying SENS stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Senseonics, including Akumin (AKU), LexaGene (LXG), SQI Diagnostics (SQD), Sernova (SVA), GeneNews (GEN), and LED Medical Diagnostics (LMD).

Senseonics (CSE:SENS) and Akumin (TSE:AKU) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Valuation & Earnings

This table compares Senseonics and Akumin's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics$4.95 million0.00C$-329,066,641.15-0.77N/A
AkuminC$246.08 million1.09C$-25,053,546.00C($0.36)-10.73

Akumin has higher revenue and earnings than Senseonics. Akumin is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Senseonics and Akumin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SenseonicsN/AN/AN/A
AkuminN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations for Senseonics and Akumin, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Senseonics0000N/A
Akumin01102.50

Akumin has a consensus price target of C$4.25, suggesting a potential upside of 10.97%.

Summary

Akumin beats Senseonics on 4 of the 4 factors compared between the two stocks.

LexaGene (CVE:LXG) and Senseonics (CSE:SENS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for LexaGene and Senseonics, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
LexaGene0000N/A
Senseonics0000N/A

Earnings & Valuation

This table compares LexaGene and Senseonics' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LexaGeneN/AN/AN/AC($0.12)-5.04
Senseonics$4.95 million0.00$-329,066,641.15-0.77N/A

LexaGene has higher earnings, but lower revenue than Senseonics. LexaGene is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares LexaGene and Senseonics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
LexaGeneN/AN/AN/A
SenseonicsN/AN/AN/A

SQI Diagnostics (CVE:SQD) and Senseonics (CSE:SENS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and recommmendations for SQI Diagnostics and Senseonics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
SQI Diagnostics0000N/A
Senseonics0000N/A

Earnings and Valuation

This table compares SQI Diagnostics and Senseonics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SQI DiagnosticsC$977,000.00102.87$-12,264,984.00C($0.04)-8.19
Senseonics$4.95 million0.00$-329,066,641.15-0.77N/A

SQI Diagnostics has higher earnings, but lower revenue than Senseonics. SQI Diagnostics is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares SQI Diagnostics and Senseonics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SQI DiagnosticsN/AN/AN/A
SenseonicsN/AN/AN/A

Summary

SQI Diagnostics beats Senseonics on 2 of the 3 factors compared between the two stocks.

Sernova (CVE:SVA) and Senseonics (CSE:SENS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of current ratings for Sernova and Senseonics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sernova0000N/A
Senseonics0000N/A

Valuation and Earnings

This table compares Sernova and Senseonics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/AN/AC($0.03)-52.22
Senseonics$4.95 million0.00$-329,066,641.15-0.77N/A

Sernova has higher earnings, but lower revenue than Senseonics. Sernova is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Sernova and Senseonics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SernovaN/AN/AN/A
SenseonicsN/AN/AN/A

Senseonics (CSE:SENS) and GeneNews (TSE:GEN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Profitability

This table compares Senseonics and GeneNews' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SenseonicsN/AN/AN/A
GeneNewsN/AN/AN/A

Valuation and Earnings

This table compares Senseonics and GeneNews' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics$4.95 million0.00C$-329,066,641.15-0.77N/A
GeneNewsC$234,592.000.00C$-11,557,484.00C($0.07)N/A

GeneNews has lower revenue, but higher earnings than Senseonics.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Senseonics and GeneNews, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Senseonics0000N/A
GeneNews0000N/A

Summary

GeneNews beats Senseonics on 2 of the 3 factors compared between the two stocks.

LED Medical Diagnostics (CVE:LMD) and Senseonics (CSE:SENS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for LED Medical Diagnostics and Senseonics, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
LED Medical Diagnostics0000N/A
Senseonics0000N/A

Profitability

This table compares LED Medical Diagnostics and Senseonics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
LED Medical DiagnosticsN/AN/AN/A
SenseonicsN/AN/AN/A

Valuation & Earnings

This table compares LED Medical Diagnostics and Senseonics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LED Medical DiagnosticsC$14.96 million1.04$-1,512,615.00C($0.04)-10.26
Senseonics$4.95 million0.00$-329,066,641.15-0.77N/A

LED Medical Diagnostics has higher revenue and earnings than Senseonics. LED Medical Diagnostics is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks.

Summary

LED Medical Diagnostics beats Senseonics on 3 of the 3 factors compared between the two stocks.


Senseonics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
AKU
Akumin
0.9$3.83flatC$268.78 millionC$246.08 million-10.73
LXG
LexaGene
0.5$0.59flatC$83.27 millionN/A-5.04
SQD
SQI Diagnostics
0.9$0.30flatC$52.59 millionC$977,000.00-8.19
SVA
Sernova
0.5$1.41flatC$31.35 millionN/A-52.22Gap Up
GEN
GeneNews
0.5N/AN/AC$24.65 millionC$234,592.00-2.21
LMD
LED Medical Diagnostics
0.4$0.40flatC$15.51 millionC$14.96 million-10.26Gap Up
VPT
VentriPoint Diagnostics
0.9$0.44flatC$5.58 millionC$37,517.00-13.18News Coverage
IDL
Imaging Dynamics
0.4$0.06flatC$4.13 millionC$378,253.00-3.16News Coverage
Gap Down
DXD
3D Signatures
0.5$0.04flatC$2.66 millionN/A-0.91Gap Up
MBI
Med Biogene
0.5$0.05flatC$795,000.00N/A-7.50Gap Down
BUX
(BUX)
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
IME
12144
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Up
CRL
Charles River Laboratories International
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.